Assemblymember Wood Moves Forward on Effort to Ban Copay Coupons
March 18, 2017
Asm. Jim Wood (D-Healdsburg), Chair of the Assembly Health Committee, is preparing Assembly Bill (AB) 265 to be heard in his committee at some time in the next month.
The bill would prohibit a drug manufacturer from offering in California “any discount, rebate, product voucher, or other reduction in an individual’s out-of-pocket expenses, including, but not limited to, a copayment or deductible” if a lower cost and therapeutically equivalent brand or generic drug is “available.”
CLSA has taken an oppose position on the bill due to its potential negative impact on patients for whom a prescriber has determined a certain brand medicine is necessary, among other reasons. We anticipate significant amendments to the bill prior to its hearing in Assembly Health Committee.